Professor Jennifer Walsh

All publications

Journal articles

• Moss KE, Keen R, Fang S, Zygouras A, Javaid MK, Geberhiwot T, Poole KES, Selby P, Walsh JS & Bubbear JS (2025) Mobility and quality of life in adults with paediatric-onset hypophosphatasia treated with Asfotase alfa: results from UK managed access agreement. Advances in Therapy, 42(5), 2429-2444. View this article in WRRO
• Perri G, Mathers JC, Martin-Ruiz C, Parker C, Demircan K, Chillon TS, Schomburg L, Robinson L, Stevenson EJ, Shannon OM , Muniz-Terrera G et al (2024) The association between selenium status and global and attention-specific cognition in very old adults in the Newcastle 85+ study: cross-sectional and longitudinal analyses. The American Journal of Clinical Nutrition, 120(5), 1019-1028. View this article in WRRO
• Bowles SD, Jacques R, Hill TR, Eastell R & Walsh JS (2024) Effects of high dose bolus cholecalciferol on free vitamin D metabolites, bone turnover markers and physical function. Nutrients, 16(17). View this article in WRRO
• Handforth C, Paggiosi MA, Jacques R, Gossiel F, Eastell R, Walsh JS & Brown JE (2024) The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study). Journal of Bone Oncology, 47. View this article in WRRO
• Jones AP, Debono M, Walsh J, Smith C, Hunt L & McKevitt FM (2024) Glucocorticoid prescribing in neurology. Practical Neurology, 24(4), 289-295. View this article in WRRO
• Lin Z, Henson WH, Dowling L, Walsh J, Dall’Ara E & Guo L (2024) Automatic segmentation of skeletal muscles from MR images using modified U-Net and a novel data augmentation approach. Frontiers in Bioengineering and Biotechnology, 12. View this article in WRRO
• Perri G, Mathers JC, Martin-Ruiz C, Parker C, Walsh JS, Eastell R, Demircan K, Chillon TS, Schomburg L, Robinson L & Hill TR (2024) Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study. British Journal of Nutrition, 131(5), 901-910. View this article in WRRO
• Perri G, Mathers JC, Martin-Ruiz C, Walsh JS, Eastell R, Schomburg L, Robinson L, Chillon T, Demircan K, Parker C & Hill TR (2023) The association between selenium status and musculoskeletal function in very old adults: the Newcastle 85+ study. Proceedings of the Nutrition Society, 82(OCE5). View this article in WRRO
• Hald JD, Keerie C, Weir CJ, Javaid MK, Lam W, Osborne P, Walsh J, Langdahl BL & Ralston SH (2023) Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta. BMJ Open, 13(11). View this article in WRRO
• Perri G, Mathers JC, Martin-Ruiz C, Walsh JS, Eastell R, Schomburg L, Robinson L & Hill TR (2023) Selenium status in very old adults: Insights from the Newcastle 85+ Study. Proceedings of the Nutrition Society, 82(OCE3).
• Mattia L, Gossiel F, Walsh JS & Eastell R (2023) Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover. Bone Reports, 18, 101676-101676.
• Kamenicky P, Briot K, Brandi ML, Cohen-Solal M, Crowley RK, Keen R, Kolta S, Lachmann RH, Lecoq A-L, Ralston SH , Walsh JS et al (2023) Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open, 9(1).
• Dowling L, Cuthbertson DJ & Walsh JS (2023) Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK Biobank. Obesity, 31(2), 496-505. View this article in WRRO
• Dowling L, McCloskey E, Cuthbertson DJ & Walsh JS (2023) Dynapenic abdominal obesity as a risk factor for falls. The Journal of Frailty & Aging, 12(1), 37-42. View this article in WRRO
• Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R & Walsh JS (2022) Fat, adipokines, bone structure and bone regulatory factors associations in obesity. European Journal of Endocrinology, 187(6), 743-750.
• Perri G, Hill TR, Mathers JC, Walsh JS, Gossiel F, Winther K, Frölich J, Folkestad L, Cold S & Eastell R (2022) Long‐term selenium‐yeast supplementation does not affect bone turnover markers: a randomized placebo‐controlled trial. Journal of Bone and Mineral Research, 37(11), 2165-2173. View this article in WRRO
• Mattia L, Gossiel F, Wang JY, Amin I, Kennedy MG, Walsh J & Eastell R (2022) The association in men and women between Growth Differentiation Factor 15, bone density and bone turnover. Bone Reports, 16.
• Paskins Z, Babatunde O, Sturrock A, Toh LS, Horne R, Maidment I, McCloskey E, Paskins Z, Armstrong D, Curtis E , Edwards J et al (2022) Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance. Osteoporosis International, 33(11), 2245-2257. View this article in WRRO
• Orlando G, Bubbear J, Clarke S, Keen R, Roy M, Anilkumar A, Schini M, Walsh JS, Javaid MK & Ireland A (2022) Physical function and physical activity in adults with X-linked hypophosphatemia. Osteoporosis International, 33(7), 1485-1491. View this article in WRRO
• Gossiel F, Ugur A, Peel NFA, Walsh JS & Eastell R (2022) The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis. Osteoporosis International, 33(6), 1357-1363. View this article in WRRO
• Harvey NC, Poole KE, Ralston SH, McCloskey EV, Sangan CB, Wiggins L, Jones C, Gittoes N, Compston J, Abrahamsen B , Gregson C et al (2022) Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Archives of Osteoporosis, 17(1). View this article in WRRO
• Dowling L, Duseja A, Vilaca T, Walsh JS & Goljanek‐Whysall K (2022) MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity : a systematic review. Journal of Cachexia, Sarcopenia and Muscle, 13(1), 68-85.
• Schini M, Peel N, Toronjo-Urquiza L, Thomas E, Salam S, Khwaja A, Eastell R & Walsh JS (2022) Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis. Osteoporosis International, 33(3), 737-744. View this article in WRRO
• Durkin A, DeVile C, Arundel P, Bull M, Walsh J, Bishop NJ, Hupin E, Parekh S, Nadarajah R, Offiah AC , Calder A et al (2021) Expanding the phenotype of SPARC-related osteogenesis imperfecta : clinical findings in two patients with pathogenic variants in SPARC and literature review. Journal of Medical Genetics, 59(8), 810-816. View this article in WRRO
• Vilaca T, Paggiosi M, Walsh JS, Selvarajah D & Eastell R (2021) The effects of type 1 diabetes and diabetic peripheral neuropathy on the musculoskeletal system : a case–control study. Journal of Bone and Mineral Research, 36(6), 1048-1059. View this article in WRRO
• Du J, Hartley C, Brooke-Wavell K, Paggiosi MA, Walsh JS, Li S & Silberschmidt VV (2021) High-impact exercise stimulated localised adaptation of microarchitecture across distal tibia in postmenopausal women. Osteoporosis International, 32(5), 907-919.
• Orlando G, Clarke S, Roy M, Lachmann R, Walsh J, Schini M, Kassim J & Ireland A (2021) Physical function and mobility in adults with X-linked hypophosphatemia. Bone Reports, 14.
• Walsh JS, Jacques RM, Schomburg L, Hill TR, Mathers JC, Williams GR & Eastell R (2021) Effect of selenium supplementation on musculoskeletal health in older women : a randomised, double-blind, placebo-controlled trial. The Lancet Healthy Longevity, 2(4), e212-e221. View this article in WRRO
• Walsh JS, Jacques R, Schomburg L, Hill T, Mathers J, Williams G & Eastell R (2021) Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-armRCT. Efficacy and Mechanism Evaluation, 8(6). View this article in WRRO
• Desborough R, Nicklin P, Gossiel F, Balasubramanian M, Walsh JS, Petryk A, Teynor M & Eastell R (2021) Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone, 144.
• Schini M, Hannan FM, Walsh JS & Eastell R (2021) Reference interval for albumin‐adjusted calcium based on a large UK population. Clinical Endocrinology, 94(1), 34-39. View this article in WRRO
• Schini M, Jacques R, Oakes E, Peel N, Walsh JS & Eastell R (2021) Normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT): Least significant change (LSC) for adjusted serum calcium. European Journal of Endocrinology, 184(1), K7-K10. View this article in WRRO
• Brown JE, Handforth C, Compston JE, Cross W, Parr N, Selby P, Wood S, Drudge-Coates L, Walsh JS, Mitchell C , Collinson FJ et al (2020) Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group. Journal of Bone Oncology, 25. View this article in WRRO
• Paggiosi MA, Peel N, McCloskey E, Walsh JS & Eastell R (2020) Comparison of treatment responder rates for three oral bisphosphonates: the TRIO study. Bone Reports, 13.
• Vilaca T, Paggiosi M, Walsh J, Selvarajah D & Eastell R (2020) Bone peripheral microarchitecture in type 1 diabetes with and without neuropathy; a cross-section study. Bone Reports, 13.
• Schini M, Hannan F, Walsh J & Eastell R (2020) Albumin-adjusted calcium equation and reference interval for adjusted calcium. Data from the UK Biobank. Bone Reports, 13.
• Fontalis A, Gossiel F, Schini M, Walsh J & Eastell R (2020) The effect of denosumab treatment on osteoclast precursor cells in postmenopausal osteoporosis. Bone Reports, 13.
• Schini M, Stirling R, Jacques R, Oakes E, Peel N, Walsh J & Eastell R (2020) The prevalence and natural history of normocalcaemic hypoparathyroidism in a United Kingdom referral population. Clinical Endocrinology, 93(2), 119-126. View this article in WRRO
• Perri G, Mendonça N, Jagger C, Walsh J, Eastell R, Mathers JC & Hill TR (2020) Dietary selenium intakes and musculoskeletal function in very old adults: Analysis of the Newcastle 85+ study. Nutrients, 12(7). View this article in WRRO
• Mickute G, Staley K, Delaney H, Gardiner O, Hunter A, Keen R, Lockhart L, Meade N, Newman M, Ralston S , Rush E et al (2020) Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance. Orphanet Journal of Rare Diseases, 15(1).
• Schini M, Jacques R, Oakes E, Peel N, Walsh J & Eastell R (2020) Normocalcemic hyperparathyroidism : study of its prevalence and natural history. The Journal of Clinical Endocrinology & Metabolism, 105(4). View this article in WRRO
• Paggiosi MA, Debono M, Walsh JS, Peel NFA & Eastell R (2020) Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study. Osteoporosis International, 31(4), 667-675. View this article in WRRO
• Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N & Eastell R (2020) The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. Bone, 131. View this article in WRRO
• Walsh JS, Marshall H, Smith IL, Greenfield DM, Swain J, Best E, Ashton J, Brown JM, Huddart R, Coleman RE , Snowden JA et al (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16(11), ---.
• Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, Walsh JS & Eastell R (2019) Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporosis International, 30(4), 917-922. View this article in WRRO
• Du J, Brooke-Wavell K, Paggiosi MA, Hartley C, Walsh JS, Silberschmidt VV & Li S (2019) Characterising variability and regional correlations of microstructure and mechanical competence of human tibial trabecular bone: An in-vivo HR-pQCT study.. Bone, 121, 139-148. View this article in WRRO
• Vilaca T, Walsh J & Eastell R (2019) Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures. Osteoporosis International, 30(1), 135-143. View this article in WRRO
• Gopal-Kothandapani JS, Evans LF, Walsh JS, Gossiel F, Rigby AS, Eastell R & Bishop NJ (2019) Effect of vitamin D supplementation on free and total vitamin D: a comparison of Asians vs Caucasians. Clinical Endocrinology, 90(1), 222-231. View this article in WRRO
• Schwartz JB, Gallagher JC, Jorde R, Berg V, Walsh J, Eastell R, Evans AL, Bowles S, Naylor KE, Jones KS , Schoenmakers I et al (2018) Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations.. The Journal of Clinical Endocrinology & Metabolism, 103(9), 3278-3288.
• Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS & Eastell R (2018) Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density. Osteoporosis International, 29(6), 1407-1417. View this article in WRRO
• Paggiosi MA, Yang L, Blackwell D, Walsh JS, McCloskey E, Peel N & Eastell R (2018) Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study. Osteoporosis International, 29(6), 1367-1378. View this article in WRRO
• Gossiel F, Scott JR, Paggiosi MA, Naylor KE, McCloskey EV, Peel NFA, Walsh JS & Eastell R (2018) The effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis.. Journal of Clinical Endocrinology and Metabolism, 103(4), 1302-1309.
• Eastell R & Walsh JS (2018) Microarchitecture of bone predicts fractures in older women. Nature Reviews Endocrinology, 14(5), 255-256. View this article in WRRO
• Eastell R, Pigott T, Gossiel F, Naylor KE, Walsh JS & Peel NF (2018) Management of endocrine disease: modern spectrum of bone turnover markers: are they clinically useful?. European Journal of Endocrinology, 178(1), R19-R31. View this article in WRRO
• Walsh JS, Bowles S & Evans AL (2017) Vitamin D in obesity. Current Opinion in Endocrinology & Diabetes and Obesity, 24, 389-394.
• Eastell R & Walsh JS (2017) Anabolic treatment for osteoporosis: teriparatide. Clinical Cases in Mineral and Bone Metabolism, 14(2), 173-178. View this article in WRRO
• Walsh JS, Gossiel F, Scott JR, Paggiosi MA & Eastell R (2017) Effect of age and gender on serum periostin: Relationship to cortical measures, bone turnover and hormones. Bone, 99, 8-13. View this article in WRRO
• Walsh JS & Vilaca T (2017) Obesity, type 2 diabetes and bone in adults.. Calcified Tissue International, 100(5), 528-535. View this article in WRRO
• Walsh JS (2017) Normal bone physiology, remodelling and its hormonal regulation. Surgery (United Kingdom), 36(1), 1-6. View this article in WRRO
• Walsh J, Gittoes N & Selby P (2016) SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients. Endocrine Connections, 5(5), G9-G11.
• Adaway JE, Dobson R, Walsh J, Cuthbertson DJ, Monaghan PJ, Trainer PJ, Valle JW & Keevil BG (2016) Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement. Annals of Clinical Biochemistry, 53(5), 554-560.
• Gossiel F, Hoyle C, McCloskey EV, Naylor KE, Walsh J, Peel N & Eastell R (2016) The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. Bone, 92, 94-99. View this article in WRRO
• Walsh JS, Evans AL, Bowles S, Naylor KE, Jones KS, Schoenmakers I, Jacques RM & Eastell R (2016) Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. American Journal of Clinical Nutrition. View this article in WRRO
• Greenfield DM, Blewitt A, Coleman RE, Walsh JS, Snowden JA, Ross RJM & Han TS (2016) Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age‐matched control study. Clinical Endocrinology, 84(2), 296-304.
• Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS & Eastell R (2015) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.. Osteoporosis International. View this article in WRRO
• Smith I, Swain J, Marshall H, Smith A, Walsh J, Ross R & Brown S (2015) Testosterone replacement in young male cancer survivors (TRYMS) - pragmatic adaptation of trial design for a trial struggling with recruitment. Trials, 16(S2).
• Swain J, Smith I, Smith A, Walsh J, Ross R & Marshall H (2015) TRYMS : the ethical and practical considerations of a double-blind placebo controlled randomised clinical trial. Trials, 16. View this article in WRRO
• Evans AL, Paggiosi MA, Eastell R & Walsh JS (2015) Bone Density, Microstructure and Strength in Obese and Normal Weight Men and Women in Younger and Older Adulthood. Journal of Bone and Mineral Research, 30(5), 920-928. View this article in WRRO
• Walsh JS (2015) Normal bone physiology, remodelling and its hormonal regulation. Surgery (Oxford), 33(1), 1-6.
• Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, Frangi AF, Bishop N & Eastell R (2014) Leptin may play a role in bone microstructural alterations in obese children.. Journal of Clinical Endocrinology & Metabolism, 100(2), 594-602. View this article in WRRO
• Paggiosi MA, Peel N, McCloskey E, Walsh JS & Eastell R (2014) Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study. Osteoporosis International, 25(12), 2729-2741.
• Bishop NJ & Walsh JS (2014) Osteogenesis imperfecta in adults. Journal of Clinical Investigation, 124(2), 476-477.
• Paggiosi MA, Eastell R & Walsh JS (2014) Precision of high-resolution peripheral quantitative computed tomography measurement variables: influence of gender, examination site, and age.. Calcif Tissue Int, 94(2), 191-201.
• Walsh JS & Eastell R (2013) Osteoporosis in men.. Nat Rev Endocrinol, 9(11), 637-645.
• Eastell R & Walsh JS (2013) Is it time to combine osteoporosis therapies?. Lancet, 382(9886), 5-7.
• Walsh JS, Newell-Price JD, DeBono M, Adaway J, Keevil B & Eastell R (2013) Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome.. J Clin Endocrinol Metab, 98(7), 2902-2907.
• Walsh JS & Eastell R (2013) Role of estrogen in the age-related decline in bone microstructure.. J Clin Endocrinol Metab, 98(2), 519-521.
• Walsh JS, Paggiosi MA & Eastell R (2012) Cortical consolidation of the radius and tibia in young men and women.. J Clin Endocrinol Metab, 97(9), 3342-3348.
• Walsh JS, Newman C & Eastell R (2012) Heart drugs that affect bone.. Trends Endocrinol Metab, 23(4), 163-168.
• Dimitri P, Bishop N, Walsh JS & Eastell R (2012) Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox.. Bone, 50(2), 457-466.
• Smith CM, Wright NP, Wales JKH, MacKenzie C, Primhak RA, Eastell R & Walsh JS (2011) Very low birth weight survivors have reduced peak bone mass and reduced insulin sensitivity. Clinical Endocrinology, 75(4), 443-449.
• Eastell R, Walsh JS, Watts NB & Siris E (2011) Bisphosphonates for postmenopausal osteoporosis.. Bone, 49(1), 82-88.
• Walsh JS & Henriksen DB (2010) Feeding and bone.. Arch Biochem Biophys, 503(1), 11-19.
• Walsh JS, Eastell R, Coleman RE, Snowden JA, Shalet SM, Ross RJ & Greenfield DM (2010) Increased fat mass may be protective of bone mass in young male cancer survivors. Bone, 47, S189-S190.
• Walsh JS, Henry YM, Fatayerji D & Eastell R (2010) Hormonal determinants of bone turnover before and after attainment of peak bone mass.. Clin Endocrinol (Oxf), 72(3), 320-327.
• Coleman RE & Walsh JS (2010) BONE Causes of low bone mass in breast cancer-time for action?. NAT REV ENDOCRINOL, 6(1), 10-12.
• Walsh JS, Eastell R & Peel NF (2010) Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.. Fertil Steril, 93(3), 697-701.
• Walsh J & Eastell R (2009) Effects of Feeding on Bone Metabolism. Clinical Reviews in Bone and Mineral Metabolism, 7(3), 230-239.
• Walsh JS, Henry YM, Fatayerji D & Eastell R (2009) Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study.. Osteoporos Int, 20(3), 355-362.
• Walsh JS, Eastell R & Peel NFA (2008) Effects of Depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study.. J Clin Endocrinol Metab, 93(4), 1317-1323.
• Hald JD, Weir C, Keerie C, Dewar L, MacLean M, Milne L, Keen R, Walsh J, Poole K, Langdahl B , Lindsay JR et al () Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta. Calcified Tissue International, 116(1).
• Bubbear J, Lachmann R, Murphy E, Krishna G, Clunie GPR, Walsh J, Schini M, Salam S, Roy M, Finezilber Y , Mathieson L et al () Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphataemia (XLH) in the UK. Calcified Tissue International, 116(1).
• Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS & Eastell R () Bone turnover markers: response to comments by Seeman and Nguyen.. Osteoporosis International. View this article in WRRO
• Greenfield D, Blewitt A, Coleman R, Walsh J, Snowden J, Ross R & Han T () Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age-matched control study. Endocrine Abstracts.
• Gossiel F, Naylor K, McCloskey E, Peel N, Walsh J, Paggiosi M & Eastell R () The effect of bisphosphonate treatment on sclerostin levels in postmenopausal osteoporosis: the TRIO study. Bone Abstracts.
• Gossiel F, Hoyle C, McCloskey E, Walsh J, Peel N & Eastell R () The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal women with rsteoporosis: The TRIO study. Bone Abstracts.
• Naylor K, Paggiosi M, Gossiel F, McCloskey E, Peel N, Walsh J & Eastell R () Determinants of bone turnover marker response to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Bone Abstracts.

Book chapters

• Hossain M, Pezaro C, Walsh J, Rathbone E & Brown J (2019) Metabolic complications In Young A, Board RE, Leonard P, Cooksley T, Stewart A & Michie C (Ed.), Problem Solving in Acute Oncology (pp. 84-88). ebn Health View this article in WRRO
• Rathbone E, Brown J & Walsh J (2013) Metabolic Complications In Marshall E, Clark P, Selby P & Young A (Ed.), Problem Solving in Acute Oncology Clinical Publishing

Conference proceedings

• Bubbear J, Lachmann R, Murphy E, Krishna G, Clunie G, Walsh J, Schini M, Salam S, Roy M, Mathieson L , Hayes V et al (2024) Patient reported outcomes (PROs) from a real-world study of burosumab treatment in adults with X-linked hypophosphatemia (XLH) in the UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 39 (pp 69-69)
• Moss K, Keen R, Fang S, Zygouras A, Javaid M, Geberhiwot T, Poole K, Selby P, Walsh J & Bubbear J (2023) MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S45-S45)
• Duseja A, Gossiel F, Paggiosi M, Walsh J, Frost M, Hermann P & Eastell R (2023) Bone turnover and bone balance in type 2 diabetes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 312-312)
• Moss KE, Keen R, Fang S, Zygouras A, Javaid M, Geberhiwot T, Poole K, Selby P, Walsh JS & Bubbear JS (2023) Mobility and Health-related Quality of Life in Adults with Pediatric-onset Hypophosphatasia Treated With Asfotase Alfa: Interim Analysis From the UK Managed Access Agreement. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 12-12)
• Schini M, Peel N, Toronjo-Urquiza L, Thomas E, Salam S, Khwaja A, Eastell R & Walsh J (2022) 1060: Renal safety of zoledronic acid in patients with borderline kidney function at a metabolic bone centre In the United Kingdom. Journal of Bone and Mineral Research, Vol. 37(S1) (pp S271-S271). San Diego, California, 1 October 2021 - 1 October 2021. View this article in WRRO
• Vilaca T, Gossiel F, Schalkwijk C, Walsh J, Selvarajah D & Eastell R (2022) Association of Bone Turnover Markers and Advanced Glycation End Products in Type 1 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 79-79)
• Schini M, Peel N, Toronjo-Urquiza L, Thomas E, Salam S, Khwaja A, Eastell R & Walsh J (2021) RENAL SAFETY OF ZOLEDRONIC ACID IN PATIENTS WITH BORDERLINE KIDNEY FUNCTION AT A METABOLIC BONE CENTRE IN THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S194-S195)
• Perri G, Hill T, Mathers JC, Walsh J, Gossiel F, Winther K, Frölich J, Folkestad L, Cold S & Eastell R (2021) Effect of selenium supplementation on biomarkers of bone turnover. Proceedings of the Nutrition Society, Vol. 80(OCE3) (pp e110). Online, 22 June 2021 - 22 June 2021. View this article in WRRO
• Schini M, Jacques R, Oakes E, Peel N, Walsh J & Eastell R (2020) NORMOCALCEMIC HYPERPARATHYROIDISM: STUDY OF THE PREVALENCE AND NATURAL HISTORY. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S192-S192)
• Schini M, Jacques R, Oakes E, Peel N, Walsh J & Eastell R (2020) Normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT): Least significant change (LSC) for adjusted serum calcium. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 55-55)
• Vilaca T, Paggiosi M, Gossiel F, Selvarajah D, Walsh J & Eastell R (2020) Bone Health in Type 1 Diabetes with and without Neuropathy; a Cross-Section Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 51-51)
• Perri G, Hill T, Mathers J, Mendonça N, Duncan R, Walsh J & Eastell R (2020) Dietary selenium intakes and their association with muscle strength and function in ≥ 85 year old adults: the Newcastle 85 + Study. Proceedings of the Nutrition Society, Vol. 79(OCE2) (pp e611). Dublin, Ireland, 15 October 2019 - 15 October 2019. View this article in WRRO
• Brown JE, Handforth C, Walsh J, Pezaro C, Sydes MR, Clarke NW, James ND & McCloskey E (2019) 857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial. Annals of Oncology, Vol. 30(Suppl 5) (pp v334-v335). Barcelona, Spain, 27 September 2019 - 27 September 2019. View this article in WRRO
• Ugur A, Gossiel F, Walsh J, Peel N & Eastell R (2018) THE CLINICAL UTILITY OF BONE FORMATION MARKERS TO MONITOR INTRAVENOUS ZOLEDRONATE TREATMENT. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 620-620)
• Schini M, Jacques R, Peel N, Walsh J & Eastell R (2018) NORMOCALCAEMIC HYPERPARATHYROIDISM: STUDY OF THE PREVALENCE AND NATURAL HISTORY IN A UNITED KINGDOM REFERRAL POPULATION. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 627-627)
• Schini M, Jacques R, Peel N, Walsh J & Eastell R (2018) Normocalcaemic Hyperparathyroidism: Study Of The Prevalence And Natural History In A United Kingdom Referral Population. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 129-129)
• Bowles S, Walsh J, Jacques R, Richard E & Hill T (2018) Effect of high dose vitamin D on free 25(OH)D and ionised calcium in vitamin D-deficient postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 400-400)
• Ugur A, Gossiel F, Naylor K, Walsh J, Peel N, Mccloskey E & Eastell R (2018) Apparent Response Rate by PINP to Oral Bisphosphonates in Clinical Practice and Clinical Trial Settings. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 319-319)
• Walsh J (2018) OSTEOPOROSIS IN YOUNG ADULTS: HOW TO INVESTIGATE AND WHEN TO TREAT. RHEUMATOLOGY, Vol. 57
• Gossiel F, Flintham L, Naylor K, Walsh J, Peel N, McCloskey E & Eastell R (2017) Offset of Effect of Oral Bisphosphonates on Tartrate-Resistant Acid Phosphatase in Postmenopausal Osteoporosis: the TRIO Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S379-S379)
• Vilaca T, Walsh J & Eastell R (2017) A meta-analysis of the risk of ankle and wrist fractures in diabetes.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S375-S376)
• Schini M, Jacques R, Peel N, Walsh J & Eastell R (2016) NORMOCALCAEMIC HYPERPARATHYROIDISM: PREVALENCE IN A UNITED KINGDOM REFERRAL POPULATION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 649-650)
• Vilaca T, Eastell R & Walsh J (2016) A META-ANALYSIS OF THE RISK OF ANKLE AND WRIST FRACTURES IN DIABETES. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 630-631)
• Gossiel F, McCloskey E, Walsh J, Naylor K, Peel N & Eastell R (2016) OC3.4: The response of fibroblast growth factor-23 to teriparatide in postmenopausal osteoporosis. Bone Abstracts, Vol. 5. Rome, Italy, 14 May 2016 - 14 May 2016. View this article in WRRO
• Adaway J, Dobson R, Walsh J, Monaghan P, Devlin N, Cuthbertson D, Valle J & Keevil BG (2014) Serum 5-Hiaa - a Better Marker of Neuroendocrine Tumour Than Urine 5-Hiaa. ENDOCRINE REVIEWS, Vol. 35(3)
• Walsh J, Evans A, Naylor K, Gossiel F, Bowles S, Jacques R & Eastell R (2014) Low Circulating 25 Hydroxyvitamin D in Obesity is not Associated with Lower 24-hour Urine Calcium, Higher Bone Turnover or Lower Bone Mineral Density. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S353-S353)
• Walsh JS, Evans AL, Naylor KE, Gossiel F, Bowles S, Jacques R & Eastell R (2014) LOW CIRCULATING 25 HYDROXYVITAMIN D IN OBESITY IS NOT ASSOCIATED WITH LOWER 24-HOUR URINE CALCIUM, HIGHER BONE TURNOVER OR LOWER BONE MINERAL DENSITY. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S672-S673)
• Evans A, Gossiel F, Naylor K, Walsh J & Eastell R (2013) Vitamin D Status in Obesity: Evaluation of Free 25(OH)D. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
• Amin M, Manley A, Evans A, Eastell R & Walsh J (2012) THE EFFECTS OF GENDER AND OBESITY ON FRACTURE RISK AND CARDIOVASCULAR RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S592-S593)
• Evans A, Walsh J & Eastell R (2012) THE EFFECT OF OBESITY ON BONE MINERAL DENSITY MEASURED AT FOUR FRACTURE SITES. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S525-S525)
• Peel N, Bull M & Walsh J (2012) HIGH DOSE COLECALCIFEROL IN THE TREATMENT OF VITAMIN D DEFICIENCY. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S571-S571)
• Walsh J, Newell-Price J, Debono M & Eastell R (2012) HIGH CIRCULATING SEROTONIN IN CARCINOID SYNDROME IS NOT ASSOCIATED WITH ALTERATIONS IN BONE TURNOVER OR BONE DENSITY. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S536-S537)
• Walsh⁎ JS, Newell-Price JD, Debono M & Eastell R (2012) High circulating serotonin in carcinoid syndrome is not associated with alterations in bone turnover or bone density. Bone, Vol. 50 (pp S53-S53)
• Walsh JS, Henry YM, Fatayerji D & Eastell R (2006) Peak bone mineral content and bone volume at the lumbar spine in males and females: Longitudinal study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S206-S207)
• Walsh JS, Henry YM, Fatayerji D & Eastell R (2006) Endocrine determinants of bone turnover in adolescence and young adulthood.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S206-S206)
• Walsh JS, Eastell R & Peel NF (2005) Effect of depot medroxyprogesterone acetate on markers of bone turnover.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S226-S226)
• Walsh JS, Eastell R & Peel NF (2005) Effect of depot medroxyprogesterone acetate on attainment of peak bone mass. BONE, Vol. 36 (pp S129-S129)
• Walsh JS, Clowes JA, Peel NF & Eastell R (2004) Bone size at the distal radius is inversely correlated with volumetric bone mineral density. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S26-S26)
• Walsh JS, Clowes JA, Peel NF & Eastell R (2004) Bone size at the distal radius is inversely correlated with volumetric bone mineral density.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S301-S301)
• Walsh JS, Eastell R & Peel NF (2003) Effect of depot medroxyprogesterone acetate on bone mineral density at the spine, hip and forearm.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S369-S369)
• Walsh JS, Evans AL, Bowles S, Naylor KE, Gossiel F, Jacques R, Schoenmakers I, Jones KS & Eastell R () Vitamin D is low in obesity, and this is due to greater volume of distribution. Bone Abstracts

Preprints

• Mickute G, Staley K, Delaney H, Gardiner O, Hunter A, Keen R, Lockhart L, Meade N, Newman M, Ralston S , Rush E et al () Rare musculoskeletal diseases in adults: a research priority setting partnership with The James Lind Alliance. View this article in WRRO